Rebekah Bernard, MD, provides tips for improving interactions with patients who are angry.
When a miscoded procedure is the result of substantial negligence or fraud, it can be detrimental to a medical practice or physician.
Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Recent research has revived the controversy regarding the role of cytoreductive nephrectomy in this setting.
Here are seven ways texting can improve healthcare revenue and decrease costs.
"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.
The CDK4/6 inhibitor abemaciclib showed clinically activity in patients with heavily pretreated metastatic castration-resistant prostate cancer.
While online reviews are critical in any industry, patient expectations are simply different when it comes to health care.
The phase 2 study explored the combination of the PD-1 inhibitor toripalimab and chemotherapy as neoadjuvant treatment for patients with upper tract urothelial carcinoma.
The device helps reduce unintentional side effects of prostate cancer therapy.
The symposium brings together clinicians devoted to solving the disease of cancer and the many challenges associated with it.
"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.
Findings from the PEACE-1 trial published in the Lancet showed that adding abiraterone acetate and prednisone to androgen-deprivation therapy and docetaxel improved overall survival in patients with de novo metastatic castration-sensitive prostate cancer.
"HIFU allows us to treat where we want and not where we don’t," writes Jennifer Linehan, MD.
Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.
Patients in the trial received switch maintenance with darolutamide following prior taxane chemotherapy and at least 1 androgen-receptor pathway inhibitor.
“Patients will never change, and demanding family members will never change. The solution to the problem is to manage the way we think about them,” writes Joan Naidorf, DO.
Multiple investigational agents have been developed and are being studied.
Here are some ways in which lawyers can remove potential jurors from a case.
Bobby Liaw, MD; Vivek K. Narayan, MD, MS; Ashley E. Ross, MD, PhD; and Neal Shore, MD, FACS, provide closing thoughts and advice for the optimal management of advanced prostate cancer.
The 5-year metastasis-free survival rate was 75% with trimodality therapy vs 74% with radical cystectomy.
Join the discussion on Health Reform with world leader in health policy and bioethics, Ezekiel J. Emanuel, MD, PhD, the Vice Provost for Global Initiatives and expert panelists and UCSF leaders.
BLC with hexaminolevulinate can be an easily replicable procedure in patients with non–muscle-invasive bladder cancer.
Recent trends in medical audits and what physicians can expect with the CMS changes in 2021 to the documentation of E/M codes.
Improvement in imaging modalities may help in performance of transurethral resection of the bladder tumor.
Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.
Cybersecurity training is vital because it is mandated by HIPAA.
Bobby Liaw, MD; Vivek K. Narayan, MD, MS; Ashley E. Ross, MD, PhD; and Neal Shore, MD, FACS, provide closing thoughts and advice for the optimal management of advanced prostate cancer.